Enzo Biochem, Inc.
SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS INFECTION
Last updated:
Abstract:
The invention provides methods and compositions for treating a coronavirus infection using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.
Status:
Application
Type:
Utility
Filling date:
10 Mar 2021
Issue date:
23 Sep 2021